期刊文献+

造血干细胞移植供受者HLA基因配型结果分析 被引量:2

下载PDF
导出
摘要 目的分析HLA基因配型结果与患者成活率的关系。方法采用准确、简便的DNA提取方法和PCR-SSP基因分型方法。结果对179例临床标本进行基因水平的研究发现,HLAPCR-SSP基因分型方法具有良好的稳定性、可靠性和特异性。配型后的15例造血干细胞移植病人,全部移植成活,现无病存活12人。结论HLA基因分型方法准确、特异、重复性好。经HLA基因配型后患者造血干细胞移植成活率高。
出处 《实验与检验医学》 CAS 2009年第2期137-137,139,共2页 Experimental and Laboratory Medicine
  • 相关文献

参考文献3

二级参考文献7

  • 1柳荣 陈世洁.中国北方汉族ABO新生溶血病发病率及其特点[J].中华儿科杂志,1986,24(1):16-16.
  • 2[1]porter DL Antin JH.The graft-versus-leukemia effects of allogeneic cell therapy[J].Annu Rev Med,1999,50:369-386.
  • 3[2]Marini FC 3rd,Kornblau SM.Produetio and culture of HSVtk transduced suicidal lymphocytces induces vafible changes in the lymphocyte s-ubset compostion[J].Bone Marrow Transpiant,1999,23:907-915.
  • 4[3]Rooney CM,Heslop HE,Brenner MK.EV specific CTL:a model for im-mune therapy[J].Vox Sang,1998,74S2:497-498.
  • 5Chia D,Tissue Antigens,1993年,42卷,146页
  • 6Lee J C,Tissue Antigens,1993年,42卷,530页
  • 7孙玉英,孔繁华,奚永志,刘楠,屠敏,金荔,陈兴国.HLA-I类PCR-SSP基因分型在异基因造血干细胞移植中的应用[J].中华器官移植杂志,2001,22(6):326-328. 被引量:10

共引文献56

同被引文献40

  • 1王希英,张国林.肺结核患者巨细胞病毒感染的血清学检测及意义[J].现代预防医学,2007,34(8):1591-1591. 被引量:4
  • 2Bittencourt H, Rocha V, Chevret S, et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation[J]. Blood, 2002, 99(8): 2726-2733.
  • 3Schulman KA, Birch R, Zhen B, et al. Effect of CD34 (+) cell dose on resource utilization in patiertts after high-dose chemoderaoy with peripheral-blood stem-cell support[J]. J clin Oncol, 1999, 17 (4): 1227.
  • 4Barnett D, Granger V, Storie I, el al. Quality assessment of CD34+ stern cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation [J]. Br J Haematol, 1998, 102(2): 553-565.
  • 5Gratama JW, Kraan J, Keeney M, et al. Validation of the single- platform ISHAGE method for CD34 (+) hematopoietic stem and progenitor cell enumeration in an international multicenter study [J]. Cytotherapy, 2003, 5(1): 55-65.
  • 6Chang A, Raik E, Marsden K, et al. Australasian CD34+ quality assurance program and rationale for the clinical utility of the sin- gle-plafform method for CD34+ cell enumeration [J]. Cytotherapy, 2004, 6(1): 50-61.
  • 7Levering WH, Preijers FW, van Wieringen WN, et al. Flow eyto- metric CD34+ stem cell enumeration: lessons from nine years ex- ternal quality assessment within the Benelux countries[J]. Cytome- try B Clin Cytom, 2007, 72(3): 178-188.
  • 8Sutherland DR, Keeney M, Gratama JW. Enumeration of CD34 + hematopoietie stem and progenitor cells [J]. Curr Protoc Cytom, 2003, Chapter 6: Unit 6 4.
  • 9Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guide- lines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering [J]. J Hematother, 1996, 5(3): 213-226.
  • 10Whitby A, Whitby L, Fletcher M, et al. 15dAtAE protocol: Are we doing it correctly? [J]. Cytometry B Clin Cytom, 2012, 82(1):9-17.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部